Non-adherence with immunosuppressive treatment is potentially one of the most significant risk factors for intra-patient variability (IPV) in drug concentrations – and one that is modifiable. The link… read more.
by Bruce Sylvester: Botox injection into fat surrounding the heart helps prevent atrial fibrillation after bypass surgery, researchers reported on Oct. 20, 2015 in Circulation: Arrhythmia and Electrophysiology.
by Bruce Sylvester: Researchers report that a genetically engineered vaccine, VGX-3100/ Inovio Pharmaceuticals, appears to eradicate high-grade precancerous cervical lesions in some women. The findings from a phase… read more.
Early intervention facilitated by a digital health application for reporting symptoms of Chronic Obstructive Pulmonary Disease (COPD) provides key benefits for patients, according to the results of a… read more.
Vijayveer Bonthapally et al, Cambridge, MA, USA / by Maria Dalby. AETHERA is a randomised, placebo-controlled phase III study to evaluate whether consolidation treatment with brentuximab vedotin can… read more.
A technique to increase the flow of blood from the umbilical cord into the infant’s circulatory system improves blood pressure and red blood cell levels in preterm infants… read more.
by Bruce Sylvester: A study of the protective effect of heart medications that patients receive before coronary artery bypass graft (CABG) surgery suggests that statins reduce the risk… read more.
by Gary Finnegan: Rapid weight loss can lead to a loss of bone mass and an increased risk of bone fractures. A study by University of Copenhagen, Hvidovre… read more.
by Gary Finnegan: Keytruda (pembrolizumab) has been recommended by the European Medicines Agency (EMA) as monotherapy for the treatment of adult patients with advanced melanoma that cannot be… read more.
by Gary Finnegan: Survival rates in young patients with high-risk neuroblastoma can be improved by Unituxin (dinutuximab), a new treatment approved by the European Medicines Agency (EMA).
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
